BIOMAT Database Logo BIOMAT Database Logo

[Insulin-secreting response to intravenous administration of tolbutamide]. 1968

E Laudicina, and G Bompiani, and G Angileri

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014044 Tolbutamide A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Apo-Tolbutamide,Artosin,Diabetol,Diaval,Dolipol,Orabet,Orinase,Rastinon,Tolbutamid R.A.N.

Related Publications

E Laudicina, and G Bompiani, and G Angileri
Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
June 1972, Israel journal of medical sciences,
E Laudicina, and G Bompiani, and G Angileri
[Serum insulin determination by radioimmunoassay after intravenous tolbutamide administration].
January 1970, Endokrynologia Polska,
E Laudicina, and G Bompiani, and G Angileri
[Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide].
January 1978, Arzneimittel-Forschung,
E Laudicina, and G Bompiani, and G Angileri
[Estimation of insulin efficacy in obesity by the response of blood insulin and glucose to intravenous tolbutamide].
January 1966, Annales d'endocrinologie,
E Laudicina, and G Bompiani, and G Angileri
Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide.
September 1965, Lancet (London, England),
E Laudicina, and G Bompiani, and G Angileri
PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION.
October 1964, The Journal of clinical endocrinology and metabolism,
E Laudicina, and G Bompiani, and G Angileri
Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics.
August 1970, Diabetologia,
E Laudicina, and G Bompiani, and G Angileri
Alloxan diabetes in the pig (Sus domesticus). Response to glucose, tolbutamide and insulin administration.
November 1971, Comparative biochemistry and physiology. A, Comparative physiology,
E Laudicina, and G Bompiani, and G Angileri
Potentiation of hypoglycemic response to intravenous tolbutamide by clofibrate.
May 1976, The New England journal of medicine,
E Laudicina, and G Bompiani, and G Angileri
Immunoreactive insulin in the portal and the peripheral venous blood after intravenous tolbutamide administration.
October 1971, Diabetes,
Copied contents to your clipboard!